Birch Hill Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.41M Sell
25,459
-79
-0.3% -$17K 0.26% 54
2026
Q1
$5.55M Sell
25,538
-437
-2% -$96.9K 0.25% 55
2025
Q4
$5.93M Sell
25,975
-1,825
-7% -$416K 0.25% 56
2025
Q3
$6.44M Sell
27,800
-100
-0.4% -$20.4K 0.27% 57
2025
Q2
$5.18M Buy
27,900
+246
+0.9% +$45.7K 0.23% 58
2025
Q1
$5.79M Sell
27,654
-182
-0.7% -$35.4K 0.27% 50
2024
Q4
$4.95M Sell
27,836
-78
-0.3% -$14.3K 0.23% 59
2024
Q3
$5.51M Hold
27,914
0.26% 57
2024
Q2
$4.79M Sell
27,914
-20
-0.1% -$3.31K 0.23% 60
2024
Q1
$5.09M Sell
27,934
-19
-0.1% -$3.27K 0.25% 54
2023
Q4
$4.33M Sell
27,953
-237
-0.8% -$34.6K 0.23% 55
2023
Q3
$4.2M Buy
28,190
+13
+0% +$1.91K 0.25% 53
2023
Q2
$3.8M Buy
28,177
+124
+0.4% +$18.2K 0.22% 59
2023
Q1
$4.47M Sell
28,053
-114
-0.4% -$17.4K 0.28% 56
2022
Q4
$4.55M Sell
28,167
-320
-1% -$49.1K 0.29% 56
2022
Q3
$3.82M Sell
28,487
-3
-0% -$430 0.26% 57
2022
Q2
$4.36M Sell
28,490
-300
-1% -$45.8K 0.27% 56
2022
Q1
$4.67M Sell
28,790
-50
-0.2% -$7.26K 0.25% 60
2021
Q4
$3.9M Buy
28,840
+14
+0% +$1.65K 0.19% 67
2021
Q3
$3.11M Hold
28,826
0.17% 69
2021
Q2
$3.25M Buy
28,826
+36
+0.1% +$4.05K 0.17% 69
2021
Q1
$3.12M Sell
28,790
-225
-0.8% -$24.1K 0.18% 69
2020
Q4
$3.11M Hold
29,015
0.19% 62
2020
Q3
$2.54M Buy
29,015
+575
+2% +$54.1K 0.17% 63
2020
Q2
$2.79M Hold
28,440
0.2% 57
2020
Q1
$2.17M Hold
28,440
0.19% 58
2019
Q4
$2.52M Hold
28,440
0.17% 66
2019
Q3
$2.15M Sell
28,440
-62
-0.2% -$4.25K 0.16% 66
2019
Q2
$2.07M Sell
28,502
-62
-0.2% -$4.87K 0.15% 71
2019
Q1
$2.3M Sell
28,564
-40
-0.1% -$3.27K 0.18% 69
2018
Q4
$2.64M Hold
28,604
0.23% 62
2018
Q3
$2.71M Buy
28,604
+233
+0.8% +$22.1K 0.2% 66
2018
Q2
$2.63M Sell
28,371
-150
-0.5% -$14.6K 0.21% 61
2018
Q1
$2.7M Buy
28,521
+740
+3% +$81.3K 0.22% 58
2017
Q4
$2.69M Sell
27,781
-1,370
-5% -$129K 0.22% 58
2017
Q3
$2.59M Sell
29,151
-1
-0% -$76 0.23% 58
2017
Q2
$2.11M Sell
29,152
-150
-0.5% -$10.1K 0.19% 59
2017
Q1
$1.91M Sell
29,302
-316
-1% -$19.9K 0.16% 62
2016
Q4
$1.85M Buy
29,618
+4
+0% +$244 0.17% 60
2016
Q3
$1.87M Buy
29,614
+502
+2% +$32.5K 0.17% 62
2016
Q2
$1.8M Sell
29,112
-1,642
-5% -$100K 0.18% 61
2016
Q1
$1.76M Buy
30,754
+188
+0.6% +$10.5K 0.18% 62
2015
Q4
$1.81M Buy
30,566
+62
+0.2% +$3.57K 0.19% 63
2015
Q3
$1.66M Sell
30,504
-100
-0.3% -$6.51K 0.18% 64
2015
Q2
$2.06M Hold
30,604
0.21% 64
2015
Q1
$1.79M Sell
30,604
-1,920
-6% -$116K 0.18% 68
2014
Q4
$2.13M Sell
32,524
-3,947
-11% -$249K 0.22% 66
2014
Q3
$2.11M Sell
36,471
-3,748
-9% -$208K 0.22% 62
2014
Q2
$2.27M Buy
40,219
+250
+0.6% +$13.1K 0.24% 62
2014
Q1
$2.05M Sell
39,969
-4,209
-10% -$213K 0.22% 62
2013
Q4
$2.33M Sell
44,178
-845
-2% -$41.5K 0.25% 62
2013
Q3
$2.01M Sell
45,023
-4,812
-10% -$213K 0.24% 64
2013
Q2
$2.06M Buy
+49,835
New +$2.18M 0.26% 64

Other funds holding ABBV

Birch Hill Investment Advisors's ABBV Position: Q2 2026 in Review

Birch Hill Investment Advisors reduced its AbbVie (ABBV) stake by 0.31% in Q2 2026, selling an estimated $17K and leaving 25,459 shares worth $6.41M. The position accounts for 0.26% of the portfolio, ranked #54.

Birch Hill Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.44M in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Birch Hill Investment Advisors held 25,459 shares of AbbVie worth $6.41M as of Q2 2026.
  • Birch Hill Investment Advisors sold 79 AbbVie shares in Q2 2026, an estimated $17K.
  • AbbVie made up 0.26% of Birch Hill Investment Advisors's portfolio in Q2 2026, its #54 holding.
  • Birch Hill Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Birch Hill Investment Advisors's AbbVie position peaked at $6.44M in Q3 2025.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Birch Hill Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.